Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial Article

sustainable development goals

publication date

  • June 1, 2020

webpage

published in

keywords

  • HDSM-Ax
  • anticholinergic
  • axillary hyperhidrosis
  • retrometabolic drug
  • sofpironium bromide
  • topical

start page

  • 1321

end page

  • 1327

volume

  • 82

issue

  • 6